Skip to main content
Pacira BioSciences, Inc. logo

Pacira BioSciences, Inc. — Investor Relations & Filings

Ticker · PCRX ISIN · US6951271005 LEI · 549300P56LERYBDHCF69 US Manufacturing
Open in API
Filings indexed 1,217 across all filing types
Latest filing 2020-08-06 Regulatory Filings
Country US United States of America
Listing US PCRX

About Pacira BioSciences, Inc.

https://www.pacira.com/

Pacira BioSciences, Inc. is a pharmaceutical company that develops, commercializes, and manufactures non-opioid pain management and regenerative health solutions. The company's mission is to provide alternatives to opioids by delivering innovative, precise, and targeted therapies. Its products and research pipeline address a diverse range of needs, including postsurgical, chronic, and musculoskeletal pain. Pacira is also focused on developing advanced solutions, including gene therapy, to address unmet needs in pain management.

Recent filings

Filing Released Lang Actions
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K/A (Amendment No. 1) filed with the SEC, which amends a previously filed Form 8-K. It corrects a typographical error in an earnings press release (Exhibit 99.1) originally filed on August 6, 2020. The document primarily serves as an amendment to a current report and includes a corrected earnings press release. The length is 4261 characters, which is relatively short and the document is an amendment to a current report, not a full financial report itself. The document is not the earnings release itself but an amendment to it. According to the rules, such filings are classified as Regulatory Filings (RNS) because they are amendments or corrections to previously filed reports and do not contain substantive financial data themselves.
2020-08-06 English
10-Q
Interim / Quarterly Report Q2 2020
2020-08-06 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events. The text specifically mentions "Item 2.02. Results of Operations and Financial Condition" and states that a press release announcing financial results for the second quarter ended June 30, 2020, is furnished as an exhibit. The document itself does not contain detailed financial statements or substantive financial data but rather references an earnings press release. The length is 3385 characters, which is relatively short and consistent with a current report announcing earnings results rather than the full earnings release document. According to the filing definitions, the initial announcement of quarterly financial results (key highlights only) corresponds to an Earnings Release (ER). Since the document is a Form 8-K announcing earnings results and includes the press release text as an exhibit, it fits best under Earnings Release (ER).
2020-08-06 English
FORM 4 SUBMISSION
Director's Dealing
2020-08-05 English
FORM 4 SUBMISSION
Director's Dealing
2020-07-17 English
FORM 8-K
Capital/Financing Update Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content details the entry into a material definitive agreement related to the issuance of convertible senior notes, including the purchase agreement, indenture, terms of the notes, and repurchase of prior notes. It also includes references to press releases announcing the offering and pricing of the notes. There are no comprehensive financial statements or detailed financial analysis typical of annual or interim reports. The document primarily provides an update on financing activities, specifically the issuance and repurchase of convertible notes, which fits the category of Capital/Financing Update. The length and detail confirm it is not a brief announcement but a substantive filing about financing transactions.
2020-07-10 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.